Scope Fluidics SA GPW:SCP:
UPDATES OBJECTIVES FOR BACTEROMIC PROJECT FOR 2026-2027
ANALYZING NEEDS OF AST END USERS LED BACTEROMIC TEAM TO FOCUS ON DEVELOPMENT, CERTIFICATION, AND COMMERCIALIZATION OF PANELS COMPATIBLE WITH FAST DETECTION SOFTWARE
RESEARCH AND DEVELOPMENT WORK WILL BE CONDUCTED ON PANELS: UNI FAST, EXTENDED UNI FAST PANEL AND PBC
PLANS TO OBTAIN CE-IVDR CERTIFICATION FOR UNI FAST PANEL IN MID-2026
FDA CERTIFICATION FOR EXPANDED VERSION OF UNI FAST PANEL IS PLANNED FOR MID-2027
EXPECTS CE-IVDR CERTIFICATION FOR PBC PANEL BY END OF 2027
DOES NOT FORESEE FDA CERTIFICATION FOR PBC PANEL BY END OF 2027
EXPECTS FIRST REVENUES FROM BACTEROMIC SYSTEM SALES IN 2026
IMPLEMENTATION OF 2026-2027 GOALS SHOULD NOT REQUIRE OBTAINING ADDITIONAL FUNDING
MANAGEMENT DECIDED TO DISCONTINUE ACTIVITIES AIMED AT SIGNING DEALS WITH EUROPEAN INVESTMENT BANK REGARDING UP TO EUR 15 MILLION FINANCING FOR BACTEROMIC PROJECT